Taken together, these results identified the CTSL–GCLC axis as a key mediator of KDM4C-loss-associated metabolomic and epigenetic remodeling and tumor growth suppression in KDM4C-amplified basal breast cancer. This evidence concerns the gene GCLC and breast carcinoma.